Find a Dermatologist | Dermatologist Directory | Dermatology Resources Online
Medicine News » Dermatology News » Incyte Announces EU Regulatory Milestone for Ruxolitinib - MarketWatch (press release)
 

Incyte Announces EU Regulatory Milestone for Ruxolitinib - MarketWatch (press release)

Posted on April 20th, 2012, 9:53 am


Incyte Announces EU Regulatory Milestone for Ruxolitinib
MarketWatch (press release)
Treatment with Jakafi can cause hematologic adverse reactions, including thrombocytopenia, anemia and neutropenia, which are each dose-related effects, with the most frequent being thrombocytopenia and anemia. A complete blood count must be performed ...

Recommend this news article 0